⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL18496344 | 0.97 | — | — | |
| Ammonia Solution, Strong SCHEMBL3657711 | 0.97 | — | — | |
| Acetic Acid SCHEMBL31169500 | 0.84 | GABRR1 (0.39) | — | |
| SCHEMBL26193306 | 0.83 | — | — | |
| SCHEMBL22853800 | 0.83 | — | — | |
| SCHEMBL23205536 | 0.83 | — | — | |
| SCHEMBL22965433 | 0.83 | — | — | |
| SCHEMBL12448104 | 0.83 | — | — | |
| SCHEMBL278465 | 0.81 | — | — | |
| SCHEMBL1535731 | 0.80 | LMNA (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 842 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12528777-B2 | Quinazolinones derivatives for treatment of non-alcoholic fatty liver disease, preparation and use thereof | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2026-01-20 | — | — | US | claimed |
| CN-117457970-B | Asymmetric heterogeneous boron center anion magnesium electrolyte salt, electrolyte, and preparation method and application thereof | 重庆大学 | 2024-07-16 | — | — | CN | claimed |
| CN-118299662-A | Low-temperature rechargeable magnesium battery electrolyte and preparation method and application thereof | 重庆大学 | 2024-07-05 | — | — | CN | claimed |
| CN-117936901-A | Rechargeable magnesium battery amine electrolyte and preparation method and application thereof | 上海交通大学 | 2024-04-26 | — | — | CN | claimed |
| CN-115692845-B | Halogen-free rechargeable magnesium battery electrolyte except fluorine, and preparation method and application thereof | 重庆大学 | 2024-02-02 | — | — | CN | claimed |
| CN-117457970-A | Asymmetric heterogeneous boron center anion magnesium electrolyte salt, electrolyte, and preparation method and application thereof | 重庆大学 | 2024-01-26 | — | — | CN | claimed |
| US-20230371525-A1 | BACILLUS ALTITUDINIS AND APPLICATION OF ACTIVE SUBSTANCE COMPOUND SOLUTION AND MICROBIAL INOCULUM THEREOF IN CONTROL OF ROOT-KNOT NEMATODE DISEASE | JIANGSU ZIBAINONG ECOLOGICAL AGRICULTURE CO., LTD (CN) | 2023-11-23 | — | — | US | claimed |
| US-20230357165-A1 | QUINAZOLINONES DERIVATIVES FOR TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE, PREPARATION AND USE THEREOF | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2023-11-09 | — | — | US | claimed |
| EP-4171569-A1 | QUINAZOLINONES DERIVATIVES FOR TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE, PREPARATION AND USE THEREOF | Council of Scientific & Industrial Research (IN) | 2023-05-03 | — | — | EP | claimed |
| CN-115692845-A | Halogen-free rechargeable magnesium battery electrolyte and preparation method and application thereof | 重庆大学 | 2023-02-03 | — | — | CN | claimed |
| US-20090163471-A1 | Tropane compounds | EXELIXIS, INC. | 2009-06-25 | — | — | US | claimed |
| WO-2009055077-A1 | TROPANE COMPOUNDS | EXELIXIS, INC. (US) | 2009-04-30 | — | — | WO | claimed |
| EP-2035372-A1 | MODULATORS OF THE HISTAMINE H3-RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | Arena Pharmaceuticals, Inc. (US) | 2009-03-18 | — | — | EP | claimed |
| US-7473706-B2 | Compounds that stimulate glucose utilization and methods of use | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2009-01-06 | — | — | US | claimed |
| US-20080286684-A1 | COATING MATERIAL FOR PHOTORESIST PATTERN AND METHOD OF FORMING FINE PATTERN USING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-11-20 | — | — | US | claimed |
| WO-2008005338-A1 | MODULATORS OF THE HISTAMINE H3-RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. (US) | 2008-01-10 | — | — | WO | claimed |
| EP-1868982-A2 | COMPOUNDS THAT STIMULATE GLUCOSE UTILIZATION AND METHODS OF USE | The Governors of the University of Alberta (CA) | 2007-12-26 | — | — | EP | claimed |
| WO-2006117686-A2 | COMPOUNDS THAT STIMULATE GLUCOSE UTILIZATION AND METHODS OF USE | THE GOVERNORS OF THE UNIVERSITY OF ALBERTA (CA) | 2006-11-09 | — | — | WO | claimed |
| US-20050182133-A1 | Compounds that stimulate glucose utilization and methods of use | UNIVERSITY OF ALBERTA (CA) | 2005-08-18 | — | — | US | claimed |
| US-5908960-A | Compounds | SMITHKLINE BEECHAM CORPORATION (US) | 1999-06-01 | — | — | US | claimed |